Home › Trial NCT00318643
Safety Study of Recombinant Human Hyaluronidase (Chemophase) in Combination With Mitomycin in Participants With Superficial Bladder Cancer
- Trial IDNCT00318643
- StatusCompleted
- PhasePhase 1/2
- Study typeInterventional
- SponsorHalozyme Therapeutics
- Enrollment27
- Start date2006-03-30
- ConditionsBladder Cancer
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.